Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 11, Issue 8, Pages 453-466
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-05-01
DOI
10.1074/mcp.m112.017483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phosphoproteomics of vasopressin signaling in the kidney
- (2011) Jason D Hoffert et al. Expert Review of Proteomics
- Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes
- (2011) Marina Pajic et al. HUMAN GENETICS
- Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells
- (2011) Peter P. Ruvolo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein
- (2011) Meng Hu et al. LEUKEMIA & LYMPHOMA
- A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer
- (2011) Markus K Muellner et al. Nature Chemical Biology
- Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms
- (2011) Pixu Liu et al. NATURE MEDICINE
- Integrative Genomic and Proteomic Analyses Identify Targets for Lkb1-Deficient Metastatic Lung Tumors
- (2010) Julian Carretero et al. CANCER CELL
- Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
- (2010) J. R. Dry et al. CANCER RESEARCH
- Use of molecular markers for predicting therapy response in cancer patients
- (2010) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- A Self-validating Quantitative Mass Spectrometry Method for Assessing the Accuracy of High-content Phosphoproteomic Experiments
- (2010) Pedro Casado et al. MOLECULAR & CELLULAR PROTEOMICS
- Confident Phosphorylation Site Localization Using the Mascot Delta Score
- (2010) Mikhail M. Savitski et al. MOLECULAR & CELLULAR PROTEOMICS
- Phosphoproteomic Analysis Reveals Interconnected System-Wide Responses to Perturbations of Kinases and Phosphatases in Yeast
- (2010) B. Bodenmiller et al. Science Signaling
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
- (2009) Mustafa Benekli et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative Phosphoproteomics of Tomato Mounting a Hypersensitive Response Reveals a Swift Suppression of Photosynthetic Activity and a Differential Role for Hsp90 Isoforms
- (2009) Iris J. E. Stulemeijer et al. JOURNAL OF PROTEOME RESEARCH
- A New Approach for Quantitative Phosphoproteomic Dissection of Signaling Pathways Applied to T Cell Receptor Activation
- (2009) Vinh Nguyen et al. MOLECULAR & CELLULAR PROTEOMICS
- Sensitive multiplexed analysis of kinase activities and activity-based kinase identification
- (2009) Kazuishi Kubota et al. NATURE BIOTECHNOLOGY
- Shifting paradigms: the seeds of oncogene addiction
- (2009) Charles L Sawyers NATURE MEDICINE
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer
- (2009) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Analytical strategies for phosphoproteomics
- (2009) Tine E. Thingholm et al. PROTEOMICS
- Challenges and Opportunities in Defining the Essential Cancer Kinome
- (2009) B. D. Manning Science Signaling
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
- (2008) V. Serra et al. CANCER RESEARCH
- Targeted therapies in breast cancer: Where are we now?
- (2008) Serena Di Cosimo et al. EUROPEAN JOURNAL OF CANCER
- The cancer biomarker problem
- (2008) Charles L. Sawyers NATURE
- Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines
- (2008) D. A. Grueneberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinase requirements in human cells: I. Comparing kinase requirements across various cell types
- (2008) D. A. Grueneberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Proliferation Gene Discovery Through Functional Genomics
- (2008) M. R. Schlabach et al. SCIENCE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- Deregulation of Signaling Pathways in Acute Myeloid Leukemia
- (2008) Claudia Scholl et al. SEMINARS IN ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now